No takes yet. Share an insight, caveat, or question.
This real-world study shows that complete tumor response predicts superior clinical outcomes in HR+/HER2- advanced breast cancer, indicating potential treatment adjustments.
Vernieri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: